Agila Biotech, a unit of Indian drugmaker Strides Arcolab
Agila Biotech will hold a 51% stake in the venture, but both parties will have equal say regarding product development and commercialisation, they said late on Tuesday.
Agila Biotech, a unit of Indian drugmaker Strides Arcolab
Agila Biotech will hold a 51% stake in the venture, but both parties will have equal say regarding product development and commercialisation, they said late on Tuesday.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 17 2013 | 5:45 PM IST